Breaking News Instant updates and real-time market news.

PRKR

ParkerVision

$1.32

0.17 (14.78%)

, AAPL

Apple

$171.85

2.37 (1.40%)

08:10
12/01/17
12/01
08:10
12/01/17
08:10

ParkerVision invited to give clarification in infringement case against Apple

ParkerVision (PRKR) announced that the Munich court rejected the request by Apple (AAPL) and certain of its' subsidiaries that ParkerVision GmbH be required to post a bond as required of a non-German entity. The court has also informed ParkerVision GmbH that it is invited to provide further clarification regarding certain elements of infringement by Apple following the finalization of this decision. A hearing was held on November 16, 2017 in this case during which both parties were allowed to present arguments regarding the alleged infringement, by Apple, of the German part of European Patent 1 135 853. Jeffrey Parker, CEO of ParkerVision, who attended the November 16th hearing, stated, "I believe our counsel was able to thoroughly explain to the court our energy sampling technology as described in the '853 Patent and furthermore, how our energy sampling technology is clearly different from sample-and-hold technologies that the defendant cited as prior art. Based on comments from the court during the hearing, we believe Apple presented oral arguments that conflicted with their written pre-hearing briefs."

PRKR

ParkerVision

$1.32

0.17 (14.78%)

AAPL

Apple

$171.85

2.37 (1.40%)

PRKR ParkerVision
$1.32

0.17 (14.78%)

AAPL Apple
$171.85

2.37 (1.40%)

11/30/17
MSCO
11/30/17
NO CHANGE
MSCO
Activated phone analysis keeps Morgan Stanley bullish on Apple outlook in China
Morgan Stanley analyst Katy Huberty responded to recent shipment data indicating that Apple's iPhone appears to be losing share in China, contending that Apple actually leads in share of the active smartphone user base there. The reasons for the divergence include the fact that Chinese vendors have been building meaningful channel inventory of inactivated smartphones and Chinese-branded smartphones have a shorter replacement cycle than the iPhone, she explains. Active market share, where Apple has gained ground, is a more accurate indicator of strength and potential upgrade demand, says Huberty, who thinks the iPhone's best days in China are still ahead. She maintains an Overweight rating and $200 price target on Apple shares.
11/30/17
PIPR
11/30/17
NO CHANGE
Target $200
PIPR
Overweight
Piper explains why Apple doesn't need to answer 'what's next?'
Piper Jaffray analyst Michael Olson sees an "ongoing drumbeat of concern" around the trajectory of Apple now that the iPhone X launch is in the rearview mirror. There are several reasons to believe that there is now less need for an imminent path to new innovation, Olson tells investors in a research note titled "Why AAPL Can Keep Working: 'Super Cycle' Is Now 'Super Long Cycle.'" The analyst believes Apple could be increasingly well positioned to experience a "strong multi-year iPhone trajectory," not the short-lived "super cycle" that was anticipated. He sees an elongated iPhone cycle and growing interest in augmented reality pushing out Apple's need to answer the question of "what's next?" Olson reiterates an Overweight rating on the shares with a $200 price target.
11/27/17
UBSW
11/27/17
NO CHANGE
UBSW
UBS says survey mixed for iPhone, positive for broader smartphone demand
UBS analyst David Mulholland said the firm's consumer survey of smartphone owners showed improving demand in China, but also the "surprising" indication that domestic OEMs are expected to benefit from this rather than Apple. The purchasing intention results were slightly below expectations for iPhone demand, but he noted the survey took place prior to the iPhone X being available in stores and hands on experience could help drive sales toward the iPhone X. The survey was mixed for iPhone but the firm now sees a stronger overall smartphone market and increased its smartphone growth forecast for 2018 to 5% from 4%.
11/27/17
NOMU
11/27/17
NO CHANGE
Target $185
NOMU
Buy
Apple multiple is 'getting full,' says Nomura Instinet
Nomura Instinet Jeffrey Kvaal says his channel checks through the holiday weekend suggest demand for Apple's iPhone X can drive upside to near-term estimates. The analyst, however, believes the stock's multiple is "getting full." Apple has traditionally traded poorly between supercycles, Kvaal tells investors in a research note. Nonetheless, he keeps a Buy rating on the shares with a $185 price target.

TODAY'S FREE FLY STORIES

NEXT

NextDecade

$5.54

0.3 (5.73%)

08:18
09/26/18
09/26
08:18
09/26/18
08:18
Downgrade
NextDecade rating change  »

NextDecade downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$94.16

-0.26 (-0.28%)

08:18
09/26/18
09/26
08:18
09/26/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$169.59

0.3 (0.18%)

08:18
09/26/18
09/26
08:18
09/26/18
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$264.73

-0.72 (-0.27%)

08:17
09/26/18
09/26
08:17
09/26/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$290.73

-0.36 (-0.12%)

08:17
09/26/18
09/26
08:17
09/26/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$28.31

-0.115 (-0.40%)

08:17
09/26/18
09/26
08:17
09/26/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$72.34

0.98 (1.37%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Recommendations
Textron analyst commentary  »

Textron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SMH

Market Vectors Semiconductor

$106.13

-1.71 (-1.59%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$72.21

0.78 (1.09%)

, BAYRY

Bayer

$0.00

(0.00%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Conference/Events
North American Spine Society to hold annual meeting »

NASS 2018 will be held in…

ABT

Abbott

$72.21

0.78 (1.09%)

BAYRY

Bayer

$0.00

(0.00%)

HRC

Hill-Rom

$91.90

0.47 (0.51%)

IART

Integra LifeSciences

$64.70

1.03 (1.62%)

MTSI

Macom

$20.20

-0.755 (-3.60%)

MDT

Medtronic

$98.99

0.14 (0.14%)

NEXS

Nexxus Lighting

$0.00

(0.00%)

NVTR

Nuvectra

$22.65

0.52 (2.35%)

PFE

Pfizer

$43.80

-0.13 (-0.30%)

SIEGY

Siemens

$0.00

(0.00%)

SYK

Stryker

$175.72

-0.37 (-0.21%)

ZBH

Zimmer Biomet

$130.50

-0.78 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 29

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 08

    Oct

  • 09

    Oct

  • 10

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 27

    Nov

QQQ

Invesco QQQ Trust

$184.13

0.25 (0.14%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$17.20

0.28 (1.65%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Hot Stocks
Nuance collaborates with KT Corporation to develop automotive assistant »

Nuance announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNG

Cheniere Energy

$68.52

0.6 (0.88%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Upgrade
Cheniere Energy rating change  »

Cheniere Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
09/26/18
09/26
08:16
09/26/18
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

08:15
09/26/18
09/26
08:15
09/26/18
08:15
Recommendations
Nike analyst commentary  »

Nike margin expansion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LKQ

LKQ Corp.

$31.90

0.17 (0.54%)

08:15
09/26/18
09/26
08:15
09/26/18
08:15
Recommendations
LKQ Corp. analyst commentary  »

LKQ Corp. shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AMZN

Amazon.com

$1,974.50

40 (2.07%)

08:14
09/26/18
09/26
08:14
09/26/18
08:14
Hot Stocks
Amazon's Alexa reported down across Europe »

Amazon's Alexa is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 04

    Oct

BNGO

Bionano Genomics

$6.30

-0.3 (-4.55%)

08:13
09/26/18
09/26
08:13
09/26/18
08:13
Initiation
Bionano Genomics initiated  »

Bionano Genomics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.39

-0.195 (-2.03%)

, BIDU

Baidu

$226.65

-0.02 (-0.01%)

08:13
09/26/18
09/26
08:13
09/26/18
08:13
Conference/Events
Bloomberg to hold a forum »

Global Business Forum…

F

Ford

$9.39

-0.195 (-2.03%)

BIDU

Baidu

$226.65

-0.02 (-0.01%)

IBM

IBM

$148.91

-1.09 (-0.73%)

JPM

JPMorgan

$116.40

-0.32 (-0.27%)

BLK

BlackRock

$478.91

-3.17 (-0.66%)

GS

Goldman Sachs

$232.39

-0.46 (-0.20%)

CS

Credit Suisse

$15.64

-0.05 (-0.32%)

UN

Unilever; also tag UL

$55.52

-0.17 (-0.31%)

UL

Unilever; also tag UN

$54.85

-0.19 (-0.35%)

BUD

AB InBev

$90.53

0.03 (0.03%)

B

Barnes Group

$71.91

0.45 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Sep

  • 01

    Oct

  • 02

    Oct

  • 12

    Oct

  • 17

    Oct

  • 21

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 13

    Nov

  • 26

    Feb

  • 03

    Mar

NATR

Natures Sunshine Products

$8.80

(0.00%)

08:13
09/26/18
09/26
08:13
09/26/18
08:13
Hot Stocks
Natures Sunshine Products CEO Gregory Probert to retire, Moorehead to succeed »

Nature's Sunshine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$75.87

-0.01 (-0.01%)

08:12
09/26/18
09/26
08:12
09/26/18
08:12
Hot Stocks
Breaking Hot Stocks news story on CarMax »

CarMax up 4.7% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

KMPH

KemPharm

$4.70

0.25 (5.62%)

, CORV

Correvio

$3.93

-0.08 (-2.00%)

08:11
09/26/18
09/26
08:11
09/26/18
08:11
Conference/Events
Oppenheimer to hold a summit »

Fall Summit on Spec…

KMPH

KemPharm

$4.70

0.25 (5.62%)

CORV

Correvio

$3.93

-0.08 (-2.00%)

NTEC

Intec Pharma

$4.80

0.45 (10.34%)

SCYX

Scynexis

$1.22

(0.00%)

ATNM

Actinium Pharmaceuticals

$0.76

0.0329 (4.52%)

CPRX

Catalyst Pharmaceuticals

$3.49

0.05 (1.45%)

REPH

Recro Pharma

$6.86

-0.36 (-4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

ERJ

Embraer

$18.85

0.23 (1.24%)

08:10
09/26/18
09/26
08:10
09/26/18
08:10
Hot Stocks
Embraer, Helvetic Airways sign contract for firm order of 12 E190-E2 jets »

Embraer and Helvetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNKN

Dunkin' Brands

$73.80

0.92 (1.26%)

08:10
09/26/18
09/26
08:10
09/26/18
08:10
Recommendations
Dunkin' Brands analyst commentary  »

Dunkin' Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:10
09/26/18
09/26
08:10
09/26/18
08:10
Conference/Events
Deutsche Bank to hold a summit »

Energy Summit will be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.